Scholarlink

Objective <p>To compare the effectiveness and safety of different acupuncture-related therapies combined with pharmacotherapies for treating symptomatic endometriosis.</p> Methods <p>A pre-defined search strategy was conducted across eight databases (Chinese Biomedical Literature Service System, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, China Science and Technology Journal Database, PubMed, Embase, Cochrane Library, and Web of Science) from inception to May 1, 2023. The included studies were evaluated for methodological quality using the Cochrane risk of bias assessment tool. The surface under the cumulative ranking (SUCRA) was applied to rank the acupuncture-related therapies for each outcome.</p> Results <p>Twenty-three randomized controlled trials (RCTs) involving one thousand five hundred forty-five patients were included in the network meta-analysis. Ear electroacupuncture (SUCRA = 83.0%), needle warming moxibustion with Modified Neiyi Zhitong Formula (SUCRA = 80.6%), and auricular needle-embedding (SUCRA = 79.6%) demonstrated a statistically significant reduction in comprehensive symptoms compared to the control group. Studies have shown that body electroacupuncture (OR = 4.33, 95% CI 1.20–15.61), acupoint catgut (OR = 4.32, 95% CI 1.08–17.25), and auricular needle-embedding (OR = 7.56, 95% CI 1.89–30.28) are statistically significantly more effective than conventional treatment.</p> Conclusion <p>The results of this analysis suggest that acupuncture-related therapies are effective in managing symptomatic endometriosis. Further high-quality randomized controlled trials are warranted to explore their efficacy and safety in greater depth.</p> Trial registration <p>Our study protocol was registered with the International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY); registration number: INPLASY202380077.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy and safety of acupuncture-related therapies in symptomatic endometriosis: a systematic review and network meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月28日

查看全文
  • Yang Su,
  • Ran Ji,
  • Xiaoyan Zheng,
  • Yan Jia,
  • Hao Zhu,
  • Chaoliang Li,
  • Zheng Yu,
  • Manjia Zhu,
  • Siyi Yu,
  • Xiaoping Tian,
  • Jie Yang

摘要

Objective

To compare the effectiveness and safety of different acupuncture-related therapies combined with pharmacotherapies for treating symptomatic endometriosis.

Methods

A pre-defined search strategy was conducted across eight databases (Chinese Biomedical Literature Service System, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, China Science and Technology Journal Database, PubMed, Embase, Cochrane Library, and Web of Science) from inception to May 1, 2023. The included studies were evaluated for methodological quality using the Cochrane risk of bias assessment tool. The surface under the cumulative ranking (SUCRA) was applied to rank the acupuncture-related therapies for each outcome.

Results

Twenty-three randomized controlled trials (RCTs) involving one thousand five hundred forty-five patients were included in the network meta-analysis. Ear electroacupuncture (SUCRA = 83.0%), needle warming moxibustion with Modified Neiyi Zhitong Formula (SUCRA = 80.6%), and auricular needle-embedding (SUCRA = 79.6%) demonstrated a statistically significant reduction in comprehensive symptoms compared to the control group. Studies have shown that body electroacupuncture (OR = 4.33, 95% CI 1.20–15.61), acupoint catgut (OR = 4.32, 95% CI 1.08–17.25), and auricular needle-embedding (OR = 7.56, 95% CI 1.89–30.28) are statistically significantly more effective than conventional treatment.

Conclusion

The results of this analysis suggest that acupuncture-related therapies are effective in managing symptomatic endometriosis. Further high-quality randomized controlled trials are warranted to explore their efficacy and safety in greater depth.

Trial registration

Our study protocol was registered with the International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY); registration number: INPLASY202380077.